VCEL
VCEL
NASDAQ · Biotechnology

Vericel Corp

$39.55
-0.47 (-1.17%)
As of Sep 21, 10:01 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +10.2% upside
Low Target $27.22
Average Target $43.60
High Target $49.94
Current Price $39.55
Current
$39.55
Target
$43.60
$27.22 $43.60 avg $49.94
Scenario Analysis
Bear Case
$27.22
-31.2%
Low target
Base Case
$43.60
+10.2%
Avg target
Bull Case
$49.94
+26.3%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$49.32
-19.8% from high
52-Week Low
$28.95
+36.6% from low
Target vs 52W High
$43.60
-11.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%